Eun Young Lee, Li-Yin Chien, Yan-Shing Chang, Seo Ah Hong, Kelly Pereira Coca
{"title":"Acceptance of the COVID-19 Vaccine Among Postpartum Women in Five Countries.","authors":"Eun Young Lee, Li-Yin Chien, Yan-Shing Chang, Seo Ah Hong, Kelly Pereira Coca","doi":"10.1089/whr.2024.0202","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This study identified factors associated with COVID-19 vaccine acceptance and willingness to receive the vaccine among postpartum women in the United Kingdom, Thailand, Taiwan, Brazil, and South Korea.</p><p><strong>Methods: </strong>An online cross-sectional survey was designed and conducted from July to November 2021. Data from 3,253 women who were up to 6 months postpartum in the United Kingdom, Thailand, Taiwan, Brazil, and South Korea were analyzed. Simple and multiple logistic regression analyses were performed.</p><p><strong>Results: </strong>Approximately 72% of women had received at least one dose of the vaccine with a range from 97.0% in Brazil to 25.2% in South Korea. Among five countries, positive attitudes and beliefs toward the COVID-19 vaccine were associated with COVID-19 vaccine acceptance (odds ratio [OR]: 1.41; 95% confidence interval [CI]: 1.35, 1.47). Higher education, paid employee status, and urban residence were associated with COVID-19 vaccine acceptance. The country-specific analysis results showed that attitudes and beliefs toward the COVID-19 vaccine were a strong predictors of COVID-19 vaccine acceptance and willingness to receive it among postpartum women.</p><p><strong>Conclusion: </strong>Positive attitudes and beliefs toward the COVID-19 vaccine and better COVID-19-related knowledge, attitudes, and practices are important for acceptance of the vaccine in postpartum women. Therefore, there is a need for sufficient and clear communication on the novel vaccine's safety and efficacy to improve awareness and attitudes among postpartum women.</p>","PeriodicalId":75329,"journal":{"name":"Women's health reports (New Rochelle, N.Y.)","volume":"6 1","pages":"482-492"},"PeriodicalIF":1.6000,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12177327/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Women's health reports (New Rochelle, N.Y.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/whr.2024.0202","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: This study identified factors associated with COVID-19 vaccine acceptance and willingness to receive the vaccine among postpartum women in the United Kingdom, Thailand, Taiwan, Brazil, and South Korea.
Methods: An online cross-sectional survey was designed and conducted from July to November 2021. Data from 3,253 women who were up to 6 months postpartum in the United Kingdom, Thailand, Taiwan, Brazil, and South Korea were analyzed. Simple and multiple logistic regression analyses were performed.
Results: Approximately 72% of women had received at least one dose of the vaccine with a range from 97.0% in Brazil to 25.2% in South Korea. Among five countries, positive attitudes and beliefs toward the COVID-19 vaccine were associated with COVID-19 vaccine acceptance (odds ratio [OR]: 1.41; 95% confidence interval [CI]: 1.35, 1.47). Higher education, paid employee status, and urban residence were associated with COVID-19 vaccine acceptance. The country-specific analysis results showed that attitudes and beliefs toward the COVID-19 vaccine were a strong predictors of COVID-19 vaccine acceptance and willingness to receive it among postpartum women.
Conclusion: Positive attitudes and beliefs toward the COVID-19 vaccine and better COVID-19-related knowledge, attitudes, and practices are important for acceptance of the vaccine in postpartum women. Therefore, there is a need for sufficient and clear communication on the novel vaccine's safety and efficacy to improve awareness and attitudes among postpartum women.